Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze UTHR stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate UTHR investment potential.

What is UTHR stock price today?

Get real-time UTHR stock price, historical data, and price charts on Financhill. Track UTHR performance with our advanced analysis tools.

Is UTHR a good investment?

Evaluate UTHR investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy UTHR stock?

To buy UTHR stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of UTHR?

View detailed market capitalization data and company valuation metrics for UTHR on our comprehensive analysis page.

What is the P/E ratio of UTHR?

Use our fundamental analysis tools to view UTHR P/E ratio and compare valuation metrics with industry peers.

What are UTHR earnings?

View UTHR earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

United Therapeutics Corp. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

UTHR
United Therapeutics Corp.

Last Price:

$484.21

Seasonality Move:

8.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed $0.81? RAD Intel Now Open at $0.85/Share

United Therapeutics Corp. Stock Forecast

Over the next 52 weeks, United Therapeutics Corp. has on average historically risen by 24.8% based on the past 26 years of stock performance.
United Therapeutics Corp. has risen higher in 17 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 65.38%
Is United Therapeutics Corp. Stock Undervalued?

The current United Therapeutics Corp. [UTHR] share price is $480.96. The Score for UTHR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
UTHR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will United Therapeutics Corp. Stock Go Up Next Year?

Over the next 52 weeks, United Therapeutics Corp. has on average historically risen by 24.8% based on the past 26 years of stock performance.

United Therapeutics Corp. Stock Rating

Buy

United Therapeutics Corp. (UTHR) is a Buy

Is United Therapeutics Corp. overpriced?

United Therapeutics Corp. has risen higher in 17 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 65.38%

United Therapeutics Corp. Stock Price History

Is UTHR stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

unither.com

52-Week Data

52-Week High:

492.62

52-Week Low:

266.98

Prediction Charts

Market Cap:

20.7B

Price in USD:

480.96

Volume:

301.5K

Beta:

0.54

Technical Analysis

SMA50:

449.61

SMA100:

392.05

SMA200:

348.65

52-Wk Change:

30.42%

Stock Predictions

Is United Therapeutics Corp. stock public?

Yes, United Therapeutics Corp. is a publicly traded company.
What is the United Therapeutics Corp. stock quote today?

The United Therapeutics Corp. stock price is 480.96 USD today.
How to buy United Therapeutics Corp. stock online?

You can buy United Therapeutics Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	460.34	466.40	470.86	460.34
Nov-17	466.40	471.92	476.70	463.93
Nov-18	469.96	476.59	485.32	469.96
Nov-19	473.82	476.54	480.90	472.10
Nov-20	477.77	474.72	482.31	473.21
Nov-21	473.37	474.82	477.64	468.51
Nov-24	472.09	477.20	482.43	466.72
Nov-25	480.86	485.77	486.20	471.05
Nov-26	485.77	488.43	492.62	483.00
Nov-28	490.25	486.00	490.30	484.35
Dec-1	484.68	479.95	486.33	477.41
Dec-2	480.14	474.14	484.24	473.51
Dec-3	474.14	480.96	482.67	470.13
Dec-4	480.63	484.10	486.46	477.56

United Therapeutics Corp. Earnings

United Therapeutics Corp. Earnings Report: Per Share United Therapeutics Corp. Earnings Q1 Q2 Q3 and Q4 last year and next year.

United Therapeutics Corp. Forecast Revenue Growth

United Therapeutics Corp. Stock Analysis: Historical quarterly revenues per share for United Therapeutics Corp. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $1.81 per share.

* United Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.